- About the TecnoCampus
- Where we are and contact information
- Undergraduate students
- eCampus degrees
- Timetables and calendars
- Future undergraduate student
- TecnoCampus Facilities
- University activities
- CRAI Library
- Continuing education students
- eCampus official masters
- eCampus diplomas and postgraduate degrees
- Future lifelong learning student
- HUB4T - Continuing Education Center
- University center
- Alumni
- Teaching staff
- Service for Quality and Teaching Innovation
- TecnoCampus quality
- Corporate information
- Communication and press room
- TecnoCampus corporate image
- Events
- Transparency portal
- Equality and Diversity Unit
- Supplier's office
- Work with us
- Entrepreneur support services
- Tools for entrepreneurs
- Aid for business creation
- Creatic Awards
- Reimagine Textile Program
- Trenlab Antenna Program
- Services for business growth
- Acceleration
- Financing
- Internationalization
- TecnoCampus Park
- Spaces to set up a company
- Park business directory
- Congress centre
- Upcoming events
- Sectoral programs
- Textile cluster
- Health cluster
- Trenlab Antenna
- Additive manufacturing and 3D printing
- Circular economy
- Sustainable business
What are you looking for?
Banting Labs gets €70.000 to develop its technology to monitor blood glucose levels
April 24, 2024
Banting Labs, based at the TecnoCampus in Mataró, has secured an investment of 70.000 euros to advance its blood glucose monitoring technology. They develop an integrated multisensor that offers continuous and real-time readings of glucose levels, without being invasive.
This funding will allow to continue with the development of the prototype and the management of the intellectual property. The company hopes to bring the product to market in 2027 to improve the quality of life for people with diabetes. The idea came from the personal experience of the CEO, whose family member was diagnosed with type 1 diabetes. The device promises to provide accurate and real-time readings, reducing the risk of hypoglycemia and improving glycemic stability for patients. The company is preparing for the first clinical trial to validate the prototype of the device.
Institution
Study
Become an entrepreneur
TecnoCampus
Tel. +34 93 169 65 00
info@tecnocampus.cat
Av. Ernest Lluch, 32 | 08302 Mataró
© 2026 TecnoCampus. All rights reserved.
Web project developed by ACTIUM Digital